The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities

Терапевтический архив

Valeriy V. Breder¹  Ekaterina V. Ershova²  Minara Sh. Shamkhalova²  Alexander Yu. Mayorov²  Ekaterina E. Mishina²  Marina V. Shestakova²  Ekaterina A. Troshina²  Ksenia A. Komshilova²  Natalia V. Korochanskaya³  Nana V. Pogosova⁴  Igor G. Nikitin⁵  Vladimir L. Doshchitsin⁵  Ekaterina N. Dudinskaya⁶  Olga N. Tkacheva⁶  Yulia V. Kotovskaya⁶  Vladimir T. Ivashkin⁷  Marina V. Maevskaya⁷  Maria Yu. Nadinskaya⁷  Khava B. Kodzoeva⁷  Aida I. Tarzimanova⁷  Natalia I. Geyvandova⁸ 

[1] Blokhin National Medical Research Center of Oncology;Endocrinology Research Centre;Kuban State Medical University;National Medical Research Center of Cardiology;Pirogov Russian National Research Medical University;Russian Clinical and Research Center of Gerontology of Pirogov Russian National Research Medical University;Sechenov First Moscow State Medical University (Sechenov University);Stavropol State Medical University;

关键词: non-alcoholic fatty liver disease;    steatosis;    inflammation;    fibrosis;    cardiovascular diseases;    metabolic disorders;    chronic kidney disease;    diagnosis;    pathogenesis;    non-drug therapy;    pharmacotherapy;    ursodeoxycholic acid;   

DOI  :  10.26442/00403660.2022.02.201363

来源: DOAJ

【 授权许可】

Unknown